Pfizer Inc. and the American Gastroenterological Association (AGA) are collaborating to offer a new grant opportunity to proposals focused on new research areas that could improve the diagnosis and treatment of inflammatory bowel disease (IBD). The Pfizer competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides details regarding specific areas
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: